Researchers from industry and two non-profit organisations have reported the discovery of two new broadly neutralising antibodies against the human immunodeficiency virus (HIV), thus advancing the goal of developing an AIDS vaccine.
Researchers from industry and two non-profit organisations have reported the discovery of two new broadly neutralising antibodies against the human immunodeficiency virus (HIV), thus advancing the goal of developing an AIDS vaccine.